Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel immunosuppressant agents disclosed in recent Actelion patent

Dec. 14, 2007

Recent patents disclose novel agents for obesity and disorders of lipoprotein metabolism

Dec. 14, 2007

Novel guanylate cyclase activators imparted in recent Bayer patent

Dec. 13, 2007

Recent AstraZeneca and Argenta patents impart new therapeutic agents for respiratory disorders

Dec. 13, 2007

New therapeutic agents for neurological disorders reported in recent patents

Dec. 13, 2007

Discovery of novel analgesic agents described in recent patent literature

Dec. 12, 2007

Novel agents for gastrointestinal disorders reported in recent patents

Dec. 12, 2007

Novel treatments for inflammatory disorders claimed in recent patents

Dec. 12, 2007

Taro patents novel antimicrobial compound isolated from Streptomyces

Dec. 11, 2007

Novel oncolytic drugs covered in recent patents

Dec. 11, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...